相关实验视频

Updated: May 7, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

针对Clp蛋白酶的BacPROTACs:对于抗菌菌药物发现的有希望的策略

Andressa Francielli Bonjorno¹, Aline Renata Pavan^1,2, Guilherme F S Fernandes³

¹School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil.

Frontiers in chemistry

|February 15, 2024

概括

新的细菌PROTAC提供了一种新的策略,通过降解必要的细菌蛋白来对抗结核病 (TB). 这种方法针对耐药菌株和潜在感染,这对于到2030年消除结核病至关重要.

科学领域:

微生物学与传染病的研究
药物发现和开发药物发现和开发
分子生物学分子生物学

背景情况:

结核病 (TB) 仍然是主要的传染病,2021年有140万例死亡.
多抗药性结核病 (MDR-TB) 和广泛抗药性结核病 (XDR-TB) 对全球根除工作构成了重大挑战.
现有的抗结核药物面临着新兴的耐药性,需要新的治疗策略.

研究的目的:

分析利用细菌蛋白质溶解机器 (BacPROTACs) 开发新的抗结核剂的蛋白质溶解化体 (PROTACs) 的潜力.
探索BacPROTACs作为克服耐药性和治疗潜在的Mycobacterium结核病感染的战略.
鼓励研究,并强调实施用于结核病治疗的BacPROTACs的挑战.

主要方法:

审查和分析PROTAC技术和细菌蛋白质降解系统的最新进展.
探索如何使用BacPROTACs来准细菌ClpC:ClpP (ClpCP) 蛋白酶.
讨论BacPROTACs对耐药和潜伏结核病菌株的应用.

主要成果:

细菌蛋白质溶解系统,类似于真核生物的泛素系统,可以被利用用于向蛋白质降解.
"BacPROTACs代表了一种有前途的途径,用于发现针对Mycobacterium tuberculosis的新型抗菌药物.
这种方法显示出开发有效治疗潜伏性和耐药结核病的药物的潜力.

结论:

"BacPROTACs提供了一种新的治疗策略,以应对迫切需要新的结核病治疗方法.
针对细菌必需蛋白质进行降解是对抗耐药性的可行方法.
进一步的研究和开发对于克服挑战和实现BacPROTACs在结核病根除方面的全部潜力至关重要.

关键词:

在Bac-PROTAC中使用.在ClpC1P1P2P1P2P1P2P1P1P1P1P1P1P1P1P1P2P1P1P1P1P1P1P1P2P1P1P1P1P1P1P1P1P1P1P1P1 结核病菌菌菌的结核病菌的结核病菌.发现药物的发现.新的药物新的药物蛋白质降解蛋白质降解结核病是一种肺结核病.

更多相关视频

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...